Xanomeline compared to other muscarinic agents on stimulation of phosphoinositide hydrolysis in vivo and other cholinomimetic effects-Reference-Cited by-同舟云学术

Xanomeline compared to other muscarinic agents on stimulation of phosphoinositide hydrolysis in vivo and other cholinomimetic effects

Published:1998-06 Issue:1-2 Volume:795 Page:179-190
ISSN:0006-8993
Container-title:Brain Research
language:en
Short-container-title:Brain Research

Author:

Bymaster Frank P.,Carter Petra A.,Peters Steven C.,Zhang Wei,Ward John S.,Mitch Charles H.,Calligaro David O.,Whitesitt Celia A.,DeLapp Neil,Shannon Harlan E.,Rimvall Karin,Jeppesen Lone,Sheardown Malcolm J.,Fink-Jensen Anders,Sauerberg Per

Publisher

Elsevier BV

Subject

Developmental Biology,Neurology (clinical),Molecular Biology,General Neuroscience

Reference51 articles.

1. Phase I clinical trials with WAL 2014, a new muscarinic agonist for the treatment of Alzheimer's disease;Adamus;Life Sci.,1995

2. Cholinergic hypothesis of geriatric memory dysfunction: a critical review;Bartus;Science,1982

3. The effects of xanomeline, an M1-selective muscarinic agonist, on cognitive and behavioral symptoms in Alzheimer's disease;Bodick;Arch. Neurol.,1997

4. Identification of a family of muscarinic acetylcholine receptor genes;Bonner;Science,1987

5. Expression of a cloned muscarinic receptor in A9 L cells;Brann;Mol. Pharmacol.,1987

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Allosteric Modulation of Muscarinic Receptors by Cholesterol, Neurosteroids and Neuroactive Steroids;International Journal of Molecular Sciences;2022-10-28

2. Characterizing the Access of Cholinergic Antagonists to Efferent Synapses in the Inner Ear;Frontiers in Neuroscience;2021-12-14

3. Crosstalk between the M1 muscarinic acetylcholine receptor and the endocannabinoid system: A relevance for Alzheimer's disease?;Cellular Signalling;2020-06

4. Continuous infusion of physostigmine in patients with perioperative septic shock: A pharmacokinetic/pharmacodynamic study with population pharmacokinetic modeling;Biomedicine & Pharmacotherapy;2019-10

5. Striatal, Hippocampal, and Cortical Networks Are Differentially Responsive to the M4- and M1-Muscarinic Acetylcholine Receptor Mediated Effects of Xanomeline;ACS Chemical Neuroscience;2018-11-27